Van ECK Associates Corp Decreases Holdings in LivaNova PLC (NASDAQ:LIVN)

Posted by on Aug 8th, 2023

Van ECK Associates Corp trimmed its stake in LivaNova PLC (NASDAQ:LIVN – Free Report) by 22.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,018 shares of the company’s stock after selling 1,729 shares during the quarter. Van ECK Associates Corp’s holdings in LivaNova were worth $262,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Western Pacific Wealth Management LP lifted its stake in LivaNova by 43.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 1,260 shares of the company’s stock valued at $70,000 after purchasing an additional 380 shares during the last quarter. Point72 Middle East FZE purchased a new position in shares of LivaNova during the 4th quarter valued at $72,000. Dupont Capital Management Corp bought a new position in shares of LivaNova during the 4th quarter worth $209,000. Guggenheim Capital LLC purchased a new stake in LivaNova in the 1st quarter worth about $215,000. Finally, NorthCrest Asset Manangement LLC raised its stake in LivaNova by 12.9% in the 1st quarter. NorthCrest Asset Manangement LLC now owns 5,240 shares of the company’s stock valued at $228,000 after acquiring an additional 600 shares during the period. 98.26% of the stock is owned by institutional investors.

LivaNova Trading Up 0.6 %

LivaNova stock opened at $57.44 on Tuesday. LivaNova PLC has a fifty-two week low of $40.26 and a fifty-two week high of $66.73. The firm’s fifty day moving average price is $51.11 and its 200-day moving average price is $49.09. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.73 and a current ratio of 3.27.

LivaNova (NASDAQ:LIVN – Get Free Report) last issued its quarterly earnings results on Wednesday, July 26th. The company reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.24. LivaNova had a negative net margin of 8.94% and a positive return on equity of 11.60%. The business had revenue of $293.90 million for the quarter, compared to analysts’ expectations of $265.05 million. During the same period last year, the business earned $0.53 earnings per share. The business’s quarterly revenue was up 15.6% on a year-over-year basis. Equities research analysts forecast that LivaNova PLC will post 2.39 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on LIVN. Needham & Company LLC reissued a “buy” rating and issued a $77.00 price target on shares of LivaNova in a research report on Monday, April 17th. Robert W. Baird boosted their target price on shares of LivaNova from $56.00 to $62.00 in a report on Thursday, July 27th. TheStreet raised LivaNova from a “d+” rating to a “c-” rating in a report on Monday, July 17th. Barclays boosted their price objective on LivaNova from $51.00 to $57.00 and gave the company an “equal weight” rating in a research note on Thursday, July 27th. Finally, Mizuho raised their target price on LivaNova from $53.00 to $60.00 in a research note on Thursday, July 27th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $67.17.

Read Our Latest Report on LIVN

About LivaNova

(Free Report)

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.

Featured Articles

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.